NasdaqGS:CRVLHealthcare
CorVel (CRVL) Launches Marketwise Repricing As Fair Value Questions Return
CorVel (CRVL) has introduced Marketwise Repricing, a market-based medical bill repricing tool that plugs into its existing bill review programs and targets complex, high-variance or out-of-network billing scenarios for clients.
See our latest analysis for CorVel.
CorVel’s launch of Marketwise Repricing comes as the stock trades at US$61.65, with the 90 day share price return up 15.02% but the 1 year total shareholder return down 40.91%. This suggests short term momentum has picked up while...